BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23107623)

  • 41. Evaluation of fluoride levels in areca nut, tobacco, and commercial smokeless tobacco products: a pilot study.
    Arakeri G; Vishal Rao US; Patil S; Patil S; Krishnamurthy MVSR; Krishnan M; Brennan PA
    Br J Oral Maxillofac Surg; 2024 Jan; 62(1):76-82. PubMed ID: 38092568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Areca nut (betel nut) chewing: a popular Indian cultural practice and its mucosal implications.
    Verma S
    Int J Dermatol; 2011 Feb; 50(2):229-32. PubMed ID: 21244394
    [No Abstract]   [Full Text] [Related]  

  • 43. Gutka consumption.
    Chaturvedi P
    Br Dent J; 2009 Apr; 206(8):397. PubMed ID: 19396186
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral submucous fibrosis - Is it time to modify the definition?
    Prasad RS; Pai A
    Oral Oncol; 2018 Dec; 87():203. PubMed ID: 30539727
    [No Abstract]   [Full Text] [Related]  

  • 45. Salivary pooling: is it specific to particular regions in oral submucous fibrosis?
    Arakeri G; Colbert S; Patil SG; Hale B; Merkx MA; Brennan PA
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):275-8. PubMed ID: 25592220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut.
    Canniff JP; Harvey W
    Int J Oral Surg; 1981; 10(Suppl 1):163-7. PubMed ID: 6807873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Odds ratio of risk factors for oral submucous fibrosis in a case control model.
    Mehrotra D; Kumar S; Agarwal GG; Asthana A; Kumar S
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):e169-73. PubMed ID: 22951384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
    Phulari RGS; Dave EJ
    Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral submucous fibrosis: a report of two pediatric cases and a brief review.
    Dhariwal R; Ray JG; Pattanayak SM; Swain N
    J Indian Soc Pedod Prev Dent; 2012; 30(1):85-8. PubMed ID: 22565524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral submucous fibrosis in children: an alarming condition and challenges in management.
    Rai A; Jain A; Arora A; Motiwale T
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33758041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychiatric morbidity among patients with oral sub-mucous fibrosis: a preliminary study.
    Mubeen K; Kumar CN; Puja R; Jigna VR; Chandrashekar H
    J Oral Pathol Med; 2010 Nov; 39(10):761-4. PubMed ID: 20923447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature.
    Yusuf H; Yong SL
    Int J Paediatr Dent; 2002 Jul; 12(4):271-6. PubMed ID: 12121538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral submucous fibrosis: an etiological dilemma.
    Sharma A; Kumar R; Johar N; Sabir H
    J Exp Ther Oncol; 2017 Nov; 12(2):163-166. PubMed ID: 29161786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betelquid.
    Babu S; Bhat RV; Kumar PU; Sesikaran B; Rao KV; Aruna P; Reddy PR
    J Toxicol Clin Toxicol; 1996; 34(3):317-22. PubMed ID: 8667470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between metabolic syndrome and oral pre-malignancy: a community- and population-based study (KCIS No. 28).
    Yen AM; Chen SL; Chiu SY; Chen HH
    Oral Oncol; 2011 Jul; 47(7):625-30. PubMed ID: 21592847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral Submucous Fibrosis Secondary to Iron Deficiency Anemia: A Case Report, Etiopathogenesis and Management.
    Bhattacharya PT; Khaitan T; Sarkar SB; Sinha R
    J Nutr Health Aging; 2016 Feb; 20(2):205-8. PubMed ID: 26812518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of an in vivo mouse model to study oral submucous fibrosis.
    Sumeth Perera MW; Gunasinghe D; Perera PA; Ranasinghe A; Amaratunga P; Warnakulasuriya S; Kaluarachchi K
    J Oral Pathol Med; 2007 May; 36(5):273-80. PubMed ID: 17448137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.
    Xu H; Lyu FY; Song JY; Xu YM; Jiang EH; Shang ZJ; Chen LL; Xu Z
    Biomed Res Int; 2021; 2021():6631856. PubMed ID: 33791368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral submucous fibrosis: a case-control study in Chennai, South India.
    Ranganathan K; Devi MU; Joshua E; Kirankumar K; Saraswathi TR
    J Oral Pathol Med; 2004 May; 33(5):274-7. PubMed ID: 15078487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analysis of areca catechu (betel) nut flavanols (tannins) in relation to oral submucous fibrosis.
    Noor Awang M
    Dent J Malays; 1987 May; 9(2):29-32. PubMed ID: 3270571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.